The nation of Zimbabwe has rejected a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's demand for sensitive data.
This rejection came to light after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "unbalanced".
A government representative has since stated that the US was seeking biological samples for research and commercial purposes while was not willing to guarantee the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged more dialogue to secure a deal suitable to both sides so the country's vital HIV programme can be sustained.
Wider Implications
This rejection follows a comparable case in Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and responsibility.
According to reports, Sixteen African countries have so far agreed to similar agreements, constituting more than $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Put simply, our country would supply the basic resources for medical research with no certainty that the end products would be available to our citizens should a future pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining frameworks previously established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.
"This system is designed to guarantee that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
Medical experts said it acknowledged the official position, but suggested that talks need to persist since much of the nation's Aids initiatives depended on international support.
"If specific concerns exist, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group said.
The situation emphasises the complex challenges between accepting much-needed foreign assistance and protecting local interests in an increasingly interconnected world.